Soy protein diet alters expression of hepatic genes regulating fatty acid and thyroid hormone metabolism in the male rat

Journal of Nutritional Biochemistry

Volumn 21, Issue 11, 2010, Pages 1106-1113

  Simmen, Frank A ^a,b   Mercado, Charles P ^a,b   Zavacki, Ann Marie ^c   Huang, Stephen A ^d   Greenway, Amy D ^a   Kang, Ping ^a   Bowman, Margaret T ^a   Prior, Ronald L ^a  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Deiodinase; Genistein; Rat; Soy protein; Thyroid hormone receptor

Indexed keywords

CASEIN; CYTOCHROME P450 4A1; FAT DROPLET; FATTY ACID; GENISTEIN; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PYRUVATE DEHYDROGENASE KINASE 4; SOYBEAN PROTEIN; THYROID HORMONE; THYROXINE DEIODINASE; TRIACYLGLYCEROL;

ABDOMINAL FAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DUODENUM; FATTY ACID METABOLISM; FEMALE; GENE EXPRESSION; MALE; NONHUMAN; PEROXISOME; PROTEIN DIET; RAT; THYROID HORMONE METABOLISM;

ANIMALS; CASEINS; DIET; FATTY ACIDS; FEMALE; GENE EXPRESSION REGULATION; GENISTEIN; IODIDE PEROXIDASE; ISOFLAVONES; LIPID METABOLISM; LIVER; MALE; PPAR ALPHA; PREGNANCY; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, THYROID HORMONE; RNA, MESSENGER; SOYBEAN PROTEINS; THYROID HORMONES;

RATTUS;

EID: 77958152180     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.09.008     Document Type: Article

References (56)

1. Velasquez M.T., Bhathena S.J. Role of dietary soy protein in obesity. Int J Med Sci 2007, 4:72-82.
2. Ørgaard A., Jensen L. The effects of soy isoflavones on obesity. Exp Biol Med (Maywood) 2008, 233:1066-1080.
3. Tovar A.R., Murguía F., Cruz C., Hernández-Pando R., Aguilar-Salinas C.A., Pedraza-Chaverri J., et al. A soy protein diet alters hepatic lipid metabolism gene expression and reduces serum lipids and renal fibrogenic cytokines in rats with chronic nephrotic syndrome. J Nutr 2002, 132:2562-2569.
4. Mezei O., Banz W.J., Steger R.W., Peluso M.R., Winters T.A., Shay N. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 2003, 133:1238-1243.
5. Ali A.A., Velasquez M.T., Hansen C.T., Mohamed A.I., Bhathena S.J. Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J Nutr Biochem 2004, 15:583-590.
6. Ascencio C., Torres N., Isoard-Acosta F., Gómez-Pérez F.J., Hernández-Pando R., Tovar A.R. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats. J Nutr 2004, 134:522-529.
7. Banz W.J., Davis J., Peterson R., Iqbal M.J. Gene expression and adiposity are modified by soy protein in male Zucker diabetic fatty rats. Obes Res 2004, 12:1907-1913.
8. Davis J., Iqbal M.J., Steinle J., Oitker J., Higginbotham D.A., Peterson R.G., et al. Soy protein influences the development of the metabolic syndrome in male obese ZDFxSHHF rats. Horm Metab Res 2005, 37:316-325.
9. Tovar A.R., Torre-Villalvazo I., Ochoa M., Elías A.L., Ortíz V., Aguilar-Salinas C.A., et al. Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats. J Lipid Res 2005, 46:1823-1832.
10. Gudbrandsen O.A., Wergedahl H., Mørk S., Liaset B., Espe M., Berge R.K. Dietary soya protein concentrate enriched with isoflavones reduced fatty liver, increased hepatic fatty acid oxidation and decreased the hepatic mRNA level of VLDL receptor in obese Zucker rats. Br J Nutr 2006, 96:249-257.
11. Davis J., Higginbotham A., O'Connor T., Moustaid-Moussa N., Tebbe A., Kim Y.C., et al. Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat. Ann Nutr Metab 2007, 51:42-52.
12. Torre-Villalvazo I., Tovar A.R., Ramos-Barragán V.E., Cerbón-Cervantes M.A., Torres N. Soy protein ameliorates metabolic abnormalities in liver and adipose tissue of rats fed a high fat diet. J Nutr 2008, 138:462-468.
13. Kim S., Sohn I., Lee Y.S., Lee Y.S. Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. J Nutr 2005, 135:33-41.
14. Iqbal M.J., Yaegashi S., Ahsan R., Lightfoot D.A., Banz W.J. Differentially abundant mRNAs in rat liver in response to diets containing soy protein isolate. Physiol Genomics 2002, 11:219-226.
15. Shukla A., Brandsch C., Bettzieche A., Hirche F., Stangl G.I., Eder K. Isoflavone-poor soy protein alters the lipid metabolism of rats by SREBP-mediated down-regulation of hepatic genes. J Nutr Biochem 2007, 18:313-321.
16. Dang Z.C., Audinot V., Papapoulos S.E., Boutin J.A., Löwik C.W. Peroxisome proliferator-activated receptor γ (PPARγ) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 2003, 278:962-967.
17. Moriyama T., Kishimoto K., Nagai K., Urade R., Ogawa T., Utsumi S., et al. Soybean β-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of β-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci Biotechnol Biochem 2004, 68:352-359.
18. Duntas L.H. Thyroid disease and lipids. Thyroid 2002, 12:287-293.
19. Cable E.E., Finn P.D., Stebbins J.W., Hou J., Ito B.R., van Poelje P.D., et al. Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. Hepatology 2009, 49:407-417.
20. Weiss R.E., Murata Y., Cua K., Hayashi Y., Seo H., Refetoff S. Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor β-deficient mice. Endocrinology 1998, 139:4945-4952.
21. Perra A., Simbula G., Simbula M., Pibiri M., Kowalik M.A., Sulas P., et al. Thyroid hormone (T3) and TRβ agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. FASEB J 2008, 22:2981-2989.
22. Araki O., Ying H., Zhu X.G., Willingham M.C., Cheng S.Y. Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. Mol Endocrinol 2009, 23:308-315.
23. Sjögren M., Alkemade A., Mittag J., Nordström K., Katz A., Rozell B., et al. Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor α1. EMBO J 2007, 26:4535-4545.
24. Liu Y.Y., Heymann R.S., Moatamed F., Schultz J.J., Sobel D., Brent G.A. A mutant thyroid hormone receptor α antagonizes peroxisome proliferator-activated receptor alpha signaling in vivo and impairs fatty acid oxidation. Endocrinology 2007, 148:1206-1217.
25. White H.L., Freeman L.M., Mahony O., Graham P.A., Hao Q., Court M.H. Effect of dietary soy on serum thyroid hormone concentrations in healthy adult cats. Am J Vet Res 2004, 65:586-591.
26. Xiao C.W., L'Abbé M.R., Gilani G.S., Cooke G.M., Curran I.H., Papademetriou S.A. Dietary soy protein isolate and isoflavones modulate hepatic thyroid hormone receptors in rats. J Nutr 2004, 134:743-749.
27. Huang W., Wood C., L'Abbé M.R., Gilani G.S., Cockell K.A., Xiao C.W. Soy protein isolate increases hepatic thyroid hormone receptor content and inhibits its binding to target genes in rats. J Nutr 2005, 135:1631-1635.
28. Kavanagh K., Jones K.L., Zhang L., Flynn D.M., Shadoan M.K., Wagner J.D. High isoflavone soy diet increases insulin secretion without decreasing insulin sensitivity in premenopausal nonhuman primates. Nutr Res 2008, 28:368-376.
29. Milerová J., Cerovská J., Zamrazil V., Bílek R., Lapcík O., Hampl R. Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters. Clin Chem Lab Med 2006, 44:171-174.
30. Hampl R., Ostatnikova D., Celec P., Putz Z., Lapcík O., Matucha P. Short-term effect of soy consumption on thyroid hormone levels and correlation with phytoestrogen level in healthy subjects. Endocr Regul 2008, 42:53-61.
31. Teas J., Braverman L.E., Kurzer M.S., Pino S., Hurley T.G., Hebert J.R. Seaweed and soy: companion foods in Asian cuisine and their effects on thyroid function in American women. J Med Food 2007, 10:90-100.
32. Field F.J., Born E., Mathur S.N. Fatty acid flux suppresses fatty acid synthesis in hamster intestine independently of SREBP-1 expression. J Lipid Res 2003, 44:1199-1208.
33. Kondo H., Minegishi Y., Komine Y., Mori T., Matsumoto I., Abe K., et al. Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A/J vs. obesity-prone C57BL/6J mice. Am J Physiol Endocrinol Metab 2006, 291:E1092-E1099.
34. Field F.J., Born E., Murthy S., Mathur S.N. Regulation of sterol regulatory element-binding proteins in hamster intestine by changes in cholesterol flux. J Biol Chem 2001, 276:17576-17583.
35. Lewis G.F., Uffelman K., Naples M., Szeto L., Haidari M., Adeli K. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster. Endocrinology 2005, 146:247-255.
36. Mori T., Kondo H., Hase T., Tokimitsu I., Murase T. Dietary fish oil upregulates intestinal lipid metabolism and reduces body weight gain in C57BL/6J mice. J Nutr 2007, 137:2629-2634.
37. Linz A.L., Xiao R., Parker J.G., Simpson P.M., Badger T.M., Simmen F.A. Feeding of soy protein isolate to rats during pregnancy and lactation suppresses formation of aberrant crypt foci in their progeny's colons: interaction of diet with fetal alcohol exposure. J Carcinog 2004, 3(1):14.
38. Xiao R., Su Y., Simmen R.C.M., Simmen F.A. Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase. Am J Physiol Gastrointest Liver Physiol 2008, 294:G868-G876.
39. Eason R.R., Till S.R., Velarde M.C., Geng Y., Chatman L., Gu L., et al. Uterine phenotype of young adult rats exposed to dietary soy or genistein during development. J Nutr Biochem 2005, 16:625-632.
40. Kurzer M.S., Xu X. Dietary phytoestrogens. Annu Rev Nutr 1997, 17:353-381.
41. Christoffolete M.A., Arrojo e Drigo R., Gazoni F., Tente S.M., Goncalves V., Amorim B.S., et al. Mice with impaired extrathyroidal thyroxine to 3,5,3'-triiodothyronine conversion maintain normal serum 3,5,3'-triiodothyronine concentrations. Endocrinology 2007, 148:954-960.
42. Xiao R., Hennings L.J., Badger T.M., Simmen F.A. Fetal programming of colon cancer in adult rats: correlations with altered neonatal growth trajectory, circulating IGF-I and IGF binding proteins, and testosterone. J Endocrinol 2007, 195:79-87.
43. Sugden M.C., Holness M.J. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol Endocrinol Metab 2003, 284:E855-E862.
44. Roche T.E., Hiromasa Y. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell Mol Life Sci 2007, 64:830-849.
45. Jeoung N.H., Harris R.A. Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. Am J Physiol Endocrinol Metab 2008, 295:E46-54.
46. Bajotto G., Murakami T., Nagasaki M., Qin B., Matsuo Y., Maeda K., et al. Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids. Metabolism 2006, 55:317-323.
47. Zhang Y., Ma K., Sadana P., Chowdhury F., Gaillard S., Wang F., et al. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J Biol Chem 2006, 281:39897-39906.
48. Takahashi Y., Ide T. Effects of soy protein and isoflavone on hepatic fatty acid synthesis and oxidation and mRNA expression of uncoupling proteins and peroxisome proliferator-activated receptor γ in adipose tissues of rats. J Nutr Biochem 2008, 19:682-693.
49. Shin E.S., Cho S.Y., Lee E.H., Lee S.J., Chang I.S., Lee T.R. Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and l-carnitine. Eur J Nutr 2006, 45:159-164.
50. Zavacki A.M., Ying H., Christoffolete M.A., Aerts G., So E., Harney J.W., et al. Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse. Endocrinology 2005, 146:1568-1575.
51. Kalaany N.Y., Gauthier K.C., Zavacki A.M., Mammen P.P., Kitazume T., Peterson J.A., et al. LXRs regulate the balance between fat storage and oxidation. Cell Metab 2005, 1:231-244.
52. Jackson-Hayes L., Song S., Lavrentyev E.N., Jansen M.S., Hillgartner F.B., Tian L., et al. A thyroid hormone response unit formed between the promoter and first intron of the carnitine palmitoyltransferase-Iα gene mediates the liver-specific induction by thyroid hormone. J Biol Chem 2003, 278:7964-7972.
53. Hodin R.A., Lazar M.A., Chin W.W. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. J Clin Invest 1990, 85(1):101-105.
54. Gereben B., Zavacki A.M., Ribich S., Kim B.W., Huang S.A., Simonides W.S., et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 2008, 29:898-938.
55. Cimmino M., Mion F., Goglia F., Minaire Y., Géloën A. Demonstration of in vivo metabolic effects of 3,5-di-iodothyronine. J Endocrinol 1996, 149:319-325.
56. Bates J.M., St Germain D.L., Galton V.A. Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology 1999, 140:844-851.